Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...
New York, USA-based rare disease firm Applied Therapeutics has announced a definitive agreement to be acquired by ...
British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...
Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.
US late-stage rare disease focused pharma Rezolute announced disappointing top-line results from its Phase III sunRIZE study ...
The US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of an oral pellet ...
A major European pharmacy meeting that combines a professional congress with a large exhibition focused on medicines and ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
California, USA-based biotech Prolynx, which is developing a next-generation portfolio of ultra-long-acting medicines for ...
Eli Lilly has shown the strength of its obesity pipeline beyond its on-market blockbuster Mounjaro (tirzepatide) ...
US biotech Amgen (Nasdaq: AMGN) has won approval from the US regulator for Uplizna (inebilizumab-cdon) to treat adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback